APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oxaliplatin Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oxaliplatin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174021360320 December 2025196 pages

Choose your research edition.

Industry ResearchOxaliplatin Injection Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxaliplatin Injection Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Oxaliplatin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxaliplatin Injection Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxaliplatin Injection Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Oxaliplatin Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oxaliplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oxaliplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oxaliplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oxaliplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oxaliplatin Injection include Teva, Sun Pharmaceutical, Qilu Pharmaceutical, Nanjing Pharmaceutical Factory, Mylan, Luoxin, Jiangsu Hengrui Medicine, Hainan Jinrui Pharmaceutical and Fresenius Kabi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oxaliplatin Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oxaliplatin Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oxaliplatin Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oxaliplatin Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Oxaliplatin Injection Segment by Company

Teva

Sun Pharmaceutical

Qilu Pharmaceutical

Nanjing Pharmaceutical Factory

Mylan

Luoxin

Jiangsu Hengrui Medicine

Hainan Jinrui Pharmaceutical

Fresenius Kabi

YRPG

Yakult honsha

Sanofi-Aventis

Lunan Pharmaceutical

Jiangsu Aosaikang Pharmaceutical

Jari Pharmaceutical

Hospira(Pfizer)

Hisun Pharmaceutical

Halfsky Pharmacy

Dr Reddy's laboratories

Chiatai Tianqing

Oxaliplatin Injection Segment by Type

Mannitol

Glucose Solution

Lactose Solution

Other

Oxaliplatin Injection Segment by Application

Colorectal Cancer

Ovarian Cancer

Stomach Cancer

Other

Oxaliplatin Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxaliplatin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxaliplatin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxaliplatin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oxaliplatin Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oxaliplatin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oxaliplatin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oxaliplatin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oxaliplatin Injection Industry Trends Table 2. Oxaliplatin Injection Industry Drivers Table 3. Oxaliplatin Injection Industry Opportunities and Challenges Table 4. Oxaliplatin Injection Industry Restraints Table 5. Global Oxaliplatin Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oxaliplatin Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oxaliplatin Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Oxaliplatin Injection Sales Market Share by Manufacturers Table 9. Global Oxaliplatin Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Oxaliplatin Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oxaliplatin Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oxaliplatin Injection Manufacturers, Product Type & Application Table 13. Global Oxaliplatin Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oxaliplatin Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Mannitol Table 17. Major Manufacturers of Glucose Solution Table 18. Major Manufacturers of Lactose Solution Table 19. Major Manufacturers of Other Table 20. Global Oxaliplatin Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Oxaliplatin Injection Sales by Type (2021-2026) & (K Units) Table 22. Global Oxaliplatin Injection Sales by Type (2027-2032) & (K Units) Table 23. Global Oxaliplatin Injection Sales Market Share by Type (2021-2026) Table 24. Global Oxaliplatin Injection Sales Market Share by Type (2027-2032) Table 25. Global Oxaliplatin Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Oxaliplatin Injection Revenue by Type (2021-2026) & (K Units) Table 27. Global Oxaliplatin Injection Revenue by Type (2027-2032) & (K Units) Table 28. Global Oxaliplatin Injection Revenue Market Share by Type (2021-2026) Table 29. Global Oxaliplatin Injection Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Colorectal Cancer Table 31. Major Manufacturers of Ovarian Cancer Table 32. Major Manufacturers of Stomach Cancer Table 33. Major Manufacturers of Other Table 34. Global Oxaliplatin Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Oxaliplatin Injection Sales by Application (2021-2026) & (K Units) Table 36. Global Oxaliplatin Injection Sales by Application (2027-2032) & (K Units) Table 37. Global Oxaliplatin Injection Sales Market Share by Application (2021-2026) Table 38. Global Oxaliplatin Injection Sales Market Share by Application (2027-2032) Table 39. Global Oxaliplatin Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Oxaliplatin Injection Revenue by Application (2021-2026) & (K Units) Table 41. Global Oxaliplatin Injection Revenue by Application (2027-2032) & (K Units) Table 42. Global Oxaliplatin Injection Revenue Market Share by Application (2021-2026) Table 43. Global Oxaliplatin Injection Revenue Market Share by Application (2027-2032) Table 44. Global Oxaliplatin Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Oxaliplatin Injection Sales by Region (2021-2026) & (K Units) Table 46. Global Oxaliplatin Injection Sales Market Share by Region (2021-2026) Table 47. Global Oxaliplatin Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Oxaliplatin Injection Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Oxaliplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Oxaliplatin Injection Sales by Country (2021-2026) & (K Units) Table 51. North America Oxaliplatin Injection Sales by Country (2027-2032) & (K Units) Table 52. Europe Oxaliplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Oxaliplatin Injection Sales by Country (2021-2026) & (K Units) Table 54. Europe Oxaliplatin Injection Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Oxaliplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Oxaliplatin Injection Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Oxaliplatin Injection Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Oxaliplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Oxaliplatin Injection Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Oxaliplatin Injection Sales by Country (2027-2032) & (K Units) Table 61. Global Oxaliplatin Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Oxaliplatin Injection Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Oxaliplatin Injection Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Oxaliplatin Injection Revenue Market Share by Region (2021-2026) Table 65. Global Oxaliplatin Injection Revenue Market Share by Region (2027-2032) Table 66. Teva Company Information Table 67. Teva Business Overview Table 68. Teva Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Teva Oxaliplatin Injection Product Portfolio Table 70. Teva Recent Development Table 71. Sun Pharmaceutical Company Information Table 72. Sun Pharmaceutical Business Overview Table 73. Sun Pharmaceutical Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sun Pharmaceutical Oxaliplatin Injection Product Portfolio Table 75. Sun Pharmaceutical Recent Development Table 76. Qilu Pharmaceutical Company Information Table 77. Qilu Pharmaceutical Business Overview Table 78. Qilu Pharmaceutical Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Qilu Pharmaceutical Oxaliplatin Injection Product Portfolio Table 80. Qilu Pharmaceutical Recent Development Table 81. Nanjing Pharmaceutical Factory Company Information Table 82. Nanjing Pharmaceutical Factory Business Overview Table 83. Nanjing Pharmaceutical Factory Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Nanjing Pharmaceutical Factory Oxaliplatin Injection Product Portfolio Table 85. Nanjing Pharmaceutical Factory Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Mylan Oxaliplatin Injection Product Portfolio Table 90. Mylan Recent Development Table 91. Luoxin Company Information Table 92. Luoxin Business Overview Table 93. Luoxin Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Luoxin Oxaliplatin Injection Product Portfolio Table 95. Luoxin Recent Development Table 96. Jiangsu Hengrui Medicine Company Information Table 97. Jiangsu Hengrui Medicine Business Overview Table 98. Jiangsu Hengrui Medicine Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Jiangsu Hengrui Medicine Oxaliplatin Injection Product Portfolio Table 100. Jiangsu Hengrui Medicine Recent Development Table 101. Hainan Jinrui Pharmaceutical Company Information Table 102. Hainan Jinrui Pharmaceutical Business Overview Table 103. Hainan Jinrui Pharmaceutical Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Hainan Jinrui Pharmaceutical Oxaliplatin Injection Product Portfolio Table 105. Hainan Jinrui Pharmaceutical Recent Development Table 106. Fresenius Kabi Company Information Table 107. Fresenius Kabi Business Overview Table 108. Fresenius Kabi Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Fresenius Kabi Oxaliplatin Injection Product Portfolio Table 110. Fresenius Kabi Recent Development Table 111. YRPG Company Information Table 112. YRPG Business Overview Table 113. YRPG Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. YRPG Oxaliplatin Injection Product Portfolio Table 115. YRPG Recent Development Table 116. Yakult honsha Company Information Table 117. Yakult honsha Business Overview Table 118. Yakult honsha Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Yakult honsha Oxaliplatin Injection Product Portfolio Table 120. Yakult honsha Recent Development Table 121. Sanofi-Aventis Company Information Table 122. Sanofi-Aventis Business Overview Table 123. Sanofi-Aventis Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Sanofi-Aventis Oxaliplatin Injection Product Portfolio Table 125. Sanofi-Aventis Recent Development Table 126. Lunan Pharmaceutical Company Information Table 127. Lunan Pharmaceutical Business Overview Table 128. Lunan Pharmaceutical Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Lunan Pharmaceutical Oxaliplatin Injection Product Portfolio Table 130. Lunan Pharmaceutical Recent Development Table 131. Jiangsu Aosaikang Pharmaceutical Company Information Table 132. Jiangsu Aosaikang Pharmaceutical Business Overview Table 133. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Product Portfolio Table 135. Jiangsu Aosaikang Pharmaceutical Recent Development Table 136. Jari Pharmaceutical Company Information Table 137. Jari Pharmaceutical Business Overview Table 138. Jari Pharmaceutical Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Jari Pharmaceutical Oxaliplatin Injection Product Portfolio Table 140. Jari Pharmaceutical Recent Development Table 141. Hospira(Pfizer) Company Information Table 142. Hospira(Pfizer) Business Overview Table 143. Hospira(Pfizer) Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Hospira(Pfizer) Oxaliplatin Injection Product Portfolio Table 145. Hospira(Pfizer) Recent Development Table 146. Hisun Pharmaceutical Company Information Table 147. Hisun Pharmaceutical Business Overview Table 148. Hisun Pharmaceutical Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Hisun Pharmaceutical Oxaliplatin Injection Product Portfolio Table 150. Hisun Pharmaceutical Recent Development Table 151. Halfsky Pharmacy Company Information Table 152. Halfsky Pharmacy Business Overview Table 153. Halfsky Pharmacy Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Halfsky Pharmacy Oxaliplatin Injection Product Portfolio Table 155. Halfsky Pharmacy Recent Development Table 156. Dr Reddy's laboratories Company Information Table 157. Dr Reddy's laboratories Business Overview Table 158. Dr Reddy's laboratories Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Dr Reddy's laboratories Oxaliplatin Injection Product Portfolio Table 160. Dr Reddy's laboratories Recent Development Table 161. Chiatai Tianqing Company Information Table 162. Chiatai Tianqing Business Overview Table 163. Chiatai Tianqing Oxaliplatin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. Chiatai Tianqing Oxaliplatin Injection Product Portfolio Table 165. Chiatai Tianqing Recent Development Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Oxaliplatin Injection Distributors List Table 169. Oxaliplatin Injection Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Oxaliplatin Injection Product Image Figure 2. Global Oxaliplatin Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oxaliplatin Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Oxaliplatin Injection Sales (2021-2032) & (K Units) Figure 5. Global Oxaliplatin Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oxaliplatin Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Mannitol Image Figure 9. Glucose Solution Image Figure 10. Lactose Solution Image Figure 11. Other Image Figure 12. Global Oxaliplatin Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Oxaliplatin Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Oxaliplatin Injection Sales Market Share by Type (2021-2032) Figure 15. Global Oxaliplatin Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Oxaliplatin Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Oxaliplatin Injection Revenue Market Share by Type (2021-2032) Figure 18. Colorectal Cancer Image Figure 19. Ovarian Cancer Image Figure 20. Stomach Cancer Image Figure 21. Other Image Figure 22. Global Oxaliplatin Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Oxaliplatin Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Oxaliplatin Injection Sales Market Share by Application (2021-2032) Figure 25. Global Oxaliplatin Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Oxaliplatin Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Oxaliplatin Injection Revenue Market Share by Application (2021-2032) Figure 28. North America Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Oxaliplatin Injection Sales Market Share by Country (2021-2032) Figure 30. U.S. Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Oxaliplatin Injection Sales Market Share by Country (2021-2032) Figure 35. Germany Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Oxaliplatin Injection Sales Market Share by Country (2021-2032) Figure 42. China Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Oxaliplatin Injection Sales Market Share by Country (2021-2032) Figure 50. Brazil Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Oxaliplatin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Oxaliplatin Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Oxaliplatin Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Oxaliplatin Injection Revenue (2021-2032) & (US$ Million) Figure 61. North America Oxaliplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Oxaliplatin Injection Revenue (2021-2032) & (US$ Million) Figure 63. Europe Oxaliplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Oxaliplatin Injection Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Oxaliplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Oxaliplatin Injection Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Oxaliplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Oxaliplatin Injection Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Oxaliplatin Injection Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Mannitol
  • Glucose Solution
  • Lactose Solution
  • Other
Applications
  • Colorectal Cancer
  • Ovarian Cancer
  • Stomach Cancer
  • Other
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Qilu Pharmaceutical
  • Nanjing Pharmaceutical Factory
  • Mylan
  • Luoxin
  • Jiangsu Hengrui Medicine
  • Hainan Jinrui Pharmaceutical
  • Fresenius Kabi
  • YRPG
  • Yakult honsha
  • Sanofi-Aventis
  • Lunan Pharmaceutical
  • Jiangsu Aosaikang Pharmaceutical
  • Jari Pharmaceutical
  • Hospira(Pfizer)
  • Hisun Pharmaceutical
  • Halfsky Pharmacy
  • Dr Reddy's laboratories
  • Chiatai Tianqing

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oxaliplatin Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oxaliplatin Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oxaliplatin Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oxaliplatin Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oxaliplatin Injection Market Dynamics
  1. 2.1 Oxaliplatin Injection Industry Trends
  2. 2.2 Oxaliplatin Injection Industry Drivers
  3. 2.3 Oxaliplatin Injection Industry Opportunities and Challenges
  4. 2.4 Oxaliplatin Injection Industry Restraints
3 Oxaliplatin Injection Market by Manufacturers
  1. 3.1 Global Oxaliplatin Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oxaliplatin Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oxaliplatin Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oxaliplatin Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oxaliplatin Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oxaliplatin Injection Manufacturers, Product Type & Application
  7. 3.7 Global Oxaliplatin Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oxaliplatin Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oxaliplatin Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oxaliplatin Injection Tier 1, Tier 2, and Tier 3
4 Oxaliplatin Injection Market by Type
  1. 4.1 Oxaliplatin Injection Type Introduction
  2. 4.1.1 Mannitol
  3. 4.1.2 Glucose Solution
  4. 4.1.3 Lactose Solution
  5. 4.1.4 Other
  6. 4.2 Global Oxaliplatin Injection Sales by Type
  7. 4.2.1 Global Oxaliplatin Injection Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Oxaliplatin Injection Sales by Type (2021-2032)
  9. 4.2.3 Global Oxaliplatin Injection Sales Market Share by Type (2021-2032)
  10. 4.3 Global Oxaliplatin Injection Revenue by Type
  11. 4.3.1 Global Oxaliplatin Injection Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Oxaliplatin Injection Revenue by Type (2021-2032)
  13. 4.3.3 Global Oxaliplatin Injection Revenue Market Share by Type (2021-2032)
5 Oxaliplatin Injection Market by Application
  1. 5.1 Oxaliplatin Injection Application Introduction
  2. 5.1.1 Colorectal Cancer
  3. 5.1.2 Ovarian Cancer
  4. 5.1.3 Stomach Cancer
  5. 5.1.4 Other
  6. 5.2 Global Oxaliplatin Injection Sales by Application
  7. 5.2.1 Global Oxaliplatin Injection Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Oxaliplatin Injection Sales by Application (2021-2032)
  9. 5.2.3 Global Oxaliplatin Injection Sales Market Share by Application (2021-2032)
  10. 5.3 Global Oxaliplatin Injection Revenue by Application
  11. 5.3.1 Global Oxaliplatin Injection Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Oxaliplatin Injection Revenue by Application (2021-2032)
  13. 5.3.3 Global Oxaliplatin Injection Revenue Market Share by Application (2021-2032)
6 Global Oxaliplatin Injection Sales by Region
  1. 6.1 Global Oxaliplatin Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oxaliplatin Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Oxaliplatin Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Oxaliplatin Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oxaliplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oxaliplatin Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oxaliplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oxaliplatin Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oxaliplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oxaliplatin Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oxaliplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oxaliplatin Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oxaliplatin Injection Revenue by Region
  1. 7.1 Global Oxaliplatin Injection Revenue by Region
  2. 7.1.1 Global Oxaliplatin Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oxaliplatin Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Oxaliplatin Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Oxaliplatin Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oxaliplatin Injection Revenue (2021-2032)
  8. 7.2.2 North America Oxaliplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oxaliplatin Injection Revenue (2021-2032)
  11. 7.3.2 Europe Oxaliplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oxaliplatin Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oxaliplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oxaliplatin Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oxaliplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Oxaliplatin Injection Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sun Pharmaceutical
  8. 8.2.1 Sun Pharmaceutical Company Information
  9. 8.2.2 Sun Pharmaceutical Business Overview
  10. 8.2.3 Sun Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Oxaliplatin Injection Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Recent Developments
  13. 8.3 Qilu Pharmaceutical
  14. 8.3.1 Qilu Pharmaceutical Company Information
  15. 8.3.2 Qilu Pharmaceutical Business Overview
  16. 8.3.3 Qilu Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Pharmaceutical Oxaliplatin Injection Product Portfolio
  18. 8.3.5 Qilu Pharmaceutical Recent Developments
  19. 8.4 Nanjing Pharmaceutical Factory
  20. 8.4.1 Nanjing Pharmaceutical Factory Company Information
  21. 8.4.2 Nanjing Pharmaceutical Factory Business Overview
  22. 8.4.3 Nanjing Pharmaceutical Factory Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nanjing Pharmaceutical Factory Oxaliplatin Injection Product Portfolio
  24. 8.4.5 Nanjing Pharmaceutical Factory Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Oxaliplatin Injection Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Luoxin
  32. 8.6.1 Luoxin Company Information
  33. 8.6.2 Luoxin Business Overview
  34. 8.6.3 Luoxin Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Luoxin Oxaliplatin Injection Product Portfolio
  36. 8.6.5 Luoxin Recent Developments
  37. 8.7 Jiangsu Hengrui Medicine
  38. 8.7.1 Jiangsu Hengrui Medicine Company Information
  39. 8.7.2 Jiangsu Hengrui Medicine Business Overview
  40. 8.7.3 Jiangsu Hengrui Medicine Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jiangsu Hengrui Medicine Oxaliplatin Injection Product Portfolio
  42. 8.7.5 Jiangsu Hengrui Medicine Recent Developments
  43. 8.8 Hainan Jinrui Pharmaceutical
  44. 8.8.1 Hainan Jinrui Pharmaceutical Company Information
  45. 8.8.2 Hainan Jinrui Pharmaceutical Business Overview
  46. 8.8.3 Hainan Jinrui Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hainan Jinrui Pharmaceutical Oxaliplatin Injection Product Portfolio
  48. 8.8.5 Hainan Jinrui Pharmaceutical Recent Developments
  49. 8.9 Fresenius Kabi
  50. 8.9.1 Fresenius Kabi Company Information
  51. 8.9.2 Fresenius Kabi Business Overview
  52. 8.9.3 Fresenius Kabi Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Fresenius Kabi Oxaliplatin Injection Product Portfolio
  54. 8.9.5 Fresenius Kabi Recent Developments
  55. 8.10 YRPG
  56. 8.10.1 YRPG Company Information
  57. 8.10.2 YRPG Business Overview
  58. 8.10.3 YRPG Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 YRPG Oxaliplatin Injection Product Portfolio
  60. 8.10.5 YRPG Recent Developments
  61. 8.11 Yakult honsha
  62. 8.11.1 Yakult honsha Company Information
  63. 8.11.2 Yakult honsha Business Overview
  64. 8.11.3 Yakult honsha Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Yakult honsha Oxaliplatin Injection Product Portfolio
  66. 8.11.5 Yakult honsha Recent Developments
  67. 8.12 Sanofi-Aventis
  68. 8.12.1 Sanofi-Aventis Company Information
  69. 8.12.2 Sanofi-Aventis Business Overview
  70. 8.12.3 Sanofi-Aventis Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sanofi-Aventis Oxaliplatin Injection Product Portfolio
  72. 8.12.5 Sanofi-Aventis Recent Developments
  73. 8.13 Lunan Pharmaceutical
  74. 8.13.1 Lunan Pharmaceutical Company Information
  75. 8.13.2 Lunan Pharmaceutical Business Overview
  76. 8.13.3 Lunan Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Lunan Pharmaceutical Oxaliplatin Injection Product Portfolio
  78. 8.13.5 Lunan Pharmaceutical Recent Developments
  79. 8.14 Jiangsu Aosaikang Pharmaceutical
  80. 8.14.1 Jiangsu Aosaikang Pharmaceutical Company Information
  81. 8.14.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  82. 8.14.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Injection Product Portfolio
  84. 8.14.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  85. 8.15 Jari Pharmaceutical
  86. 8.15.1 Jari Pharmaceutical Company Information
  87. 8.15.2 Jari Pharmaceutical Business Overview
  88. 8.15.3 Jari Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Jari Pharmaceutical Oxaliplatin Injection Product Portfolio
  90. 8.15.5 Jari Pharmaceutical Recent Developments
  91. 8.16 Hospira(Pfizer)
  92. 8.16.1 Hospira(Pfizer) Company Information
  93. 8.16.2 Hospira(Pfizer) Business Overview
  94. 8.16.3 Hospira(Pfizer) Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Hospira(Pfizer) Oxaliplatin Injection Product Portfolio
  96. 8.16.5 Hospira(Pfizer) Recent Developments
  97. 8.17 Hisun Pharmaceutical
  98. 8.17.1 Hisun Pharmaceutical Company Information
  99. 8.17.2 Hisun Pharmaceutical Business Overview
  100. 8.17.3 Hisun Pharmaceutical Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Hisun Pharmaceutical Oxaliplatin Injection Product Portfolio
  102. 8.17.5 Hisun Pharmaceutical Recent Developments
  103. 8.18 Halfsky Pharmacy
  104. 8.18.1 Halfsky Pharmacy Company Information
  105. 8.18.2 Halfsky Pharmacy Business Overview
  106. 8.18.3 Halfsky Pharmacy Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Halfsky Pharmacy Oxaliplatin Injection Product Portfolio
  108. 8.18.5 Halfsky Pharmacy Recent Developments
  109. 8.19 Dr Reddy's laboratories
  110. 8.19.1 Dr Reddy's laboratories Company Information
  111. 8.19.2 Dr Reddy's laboratories Business Overview
  112. 8.19.3 Dr Reddy's laboratories Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Dr Reddy's laboratories Oxaliplatin Injection Product Portfolio
  114. 8.19.5 Dr Reddy's laboratories Recent Developments
  115. 8.20 Chiatai Tianqing
  116. 8.20.1 Chiatai Tianqing Company Information
  117. 8.20.2 Chiatai Tianqing Business Overview
  118. 8.20.3 Chiatai Tianqing Oxaliplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Chiatai Tianqing Oxaliplatin Injection Product Portfolio
  120. 8.20.5 Chiatai Tianqing Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oxaliplatin Injection Value Chain Analysis
  2. 9.1.1 Oxaliplatin Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oxaliplatin Injection Production Mode & Process
  6. 9.2 Oxaliplatin Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oxaliplatin Injection Distributors
  9. 9.2.3 Oxaliplatin Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst